Allogeneic hematopoietic cell transplantation (alloHCT) is the intensive but optimal therapy for higher risk acute types of leukemia (AML, ALL, CML in accelerated phase (AP) or blast crisis (BC)) and ...

Whether you’ve recently received a diagnosis of Hodgkin’s lymphoma or you’re nearing the end of your treatment regimen, you may have questions about “remission” and “relapse.” Remission is a term that ...

ORLANDO, Florida — A first-of-its-kind study has shown that for patients with follicular lymphoma (FL), measurements of minimal residual disease (MRD) can be used to predict risk for relapse.

May 1, 2012 (New Orleans, Louisiana) — Results of a large randomized trial have shown that the combination interferon beta-1a and glatiramer acetate was not more effective than either agent alone on ...

Achieving complete remission should be considered the standard of care in antidepressant treatment (Thase, 1999). Succinctly, the goals of antidepressant therapy should be to: (1) reduce and ...